Objective: The aim of the present study was to determine the prevalence of overactive bladder (OAB) in individuals aged ≥40 years in China, Taiwan, and South Korea.
depending on sex and the definition of OAB used. 3, 4 When OAB was defined as the presence of urinary urgency (at least "sometimes") or the presence of urinary urgency incontinence, the reported prevalence rates in Sweden, the UK, and US were 22%, 24%, and 27%, respectively, in men and 41%, 42%, and 43%, respectively, in women. 4 An overall OAB prevalence of 11.8% was reported in the European Prospective Investigation into Cancer and Nutrition (EPIC) study of adults aged ≥18 years in Canada, Germany, Italy, Sweden, and the UK. 5 Previous studies reported an OAB prevalence of 16.5% in a US population aged ≥18 years 6 and 16.6% in European individuals aged ≥40 years. 7 Few international population-based data are available regarding the prevalence of OAB in Asia, and there is considerable variation between published estimates. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Consequently, our understanding of the true burden of OAB in Asia is limited.
The aim of the present study was to determine the prevalence of lower urinary tract symptoms (LUTS) in the population aged ≥40 years in China, Taiwan, and South Korea, using symptom definitions approved by the International Continence Society (ICS) in
2002
. 18 LUTS prevalence has been reported previously. 19 Herein we report on OAB prevalence results from that study.
| METHODS
A cross-sectional population-representative Internet-based study was conducted in China, Taiwan, and South Korea. Full details of the study methodology have been published elsewhere. 19 Individuals aged ≥40 years with Internet access and the ability to read the local language were eligible to participate in the study. The exclusion criteria were pregnancy and urinary tract infection within the preceding month. All participants provided informed consent.
Participants were from consumer survey panels with random sampling, and were representative of the target population. Cohort management accounted for sex, age, income, age group, and geography (restricted to urban areas). For each participant, general demographic data were collected. The instruments used in the study included the overactive bladder symptom score 20 (OABSS), the Inter- Participants were asked whether they followed treatment, with the following as options: prescribed medication, surgery, physical therapy, self-treatment, limiting fluid intake, limiting caffeine intake, limit alcohol intake, stopping drinking during the night, and wearing pads. 20 It PPBC, which was investigated using the Spearman method.
It was not considered necessary to submit this study for approval by an international review board because it was based on a survey.
However, the principles of the Declaration of Helsinki were followed and the study was performed in compliance with market research (ESOMAR) guidelines 24 and Good Clinical Practice.
| RESULTS
The survey sample and response rate has been reported previously. The presence of comorbid conditions was associated with statistically significant increases in OAB prevalence ( Figure 1 ; P = .001 for all comorbidities). This was true for all comorbid conditions that were analyzed, with neurological disease and diabetes being associated with the greatest increases in OAB prevalence.
Almost half of the individuals with no OAB (48%) had no LUTS according to ICS criteria (Table 4) . Conversely, 88% of individuals with severe OAB were positive for all 3 ICS symptom groups (voiding, storage, and post-micturition). Individuals without OAB were most likely to report that their bladder condition does not cause them any problems (60%; vs. 0% of individuals with severe OAB), whereas those with severe OAB were most likely to be experiencing many severe bladder-related problems (25%; vs. 0% of individuals with no OAB). These data represent a statistically significant correlation between OAB and PPBC (r = 0.753, P = .001).
Of individuals with OAB, 46% reported visiting healthcare professionals for urinary symptoms (men 47%, women 46%). This percentage increased with increasing OAB severity (P = .001) from 10%
for no OAB to 64% for severe OAB, a trend that was apparent in both men and women ( Figure 2 ). The percentage of men with severe OAB visiting a healthcare professional for urinary symptoms was higher than that of women (71% vs. 59%, respectively), but this difference was not statistically significant (P > .05). The percentage of individuals following treatment increased significantly with OAB severity (P = .001) from 38% among those with no OAB, to 67% among those with mild OAB, to 86% among those with moderate OAB, and to 94% among those with severe OAB. The most commonly followed treatments by individuals with no OAB compared with those with severe OAB were prescribed medication (19% vs. 63%, respectively; P = .001), limiting fluid intake (10% vs. 46%, respectively; P = .001), self-treatment (10% vs. 31%, respectively; P = .001), and physical therapy (7% vs. 37%, respectively; P = .001).
Increased severity of OAB was associated with reduced sexual quality of life (Table 5 ; for total score, r = -0.285, P < .0001). Among women, the mean SQOL-F total score ranged between 76.9 for those with no OAB and 61.6 for those with severe OAB. For all 5 domains of the IIEF, including sexual desire and intercourse satisfaction, men with no OAB had the highest mean score and those with severe OAB 
| DISCUSSION
The present study shows that 20.8% of the population aged ≥40 years in China, Taiwan, and South Korea fulfilled the OABSS criteria for OAB. The prevalence of OAB increased with age and was higher in women than men. The risk of OAB was higher among individuals with a range of comorbidities, particularly neurological disease and diabetes. Increased severity of OAB was associated with decreased sexual quality of life, among both men and women. Demographic data show that individuals aged ≥40 years comprise 43%, 49%, and 48% of the overall population in China, Taiwan, and South Korea, respectively. Due to low OAB prevalence rates among individuals aged <40 years, overall population prevalence rates of OAB are expected to be lower than the rates reported in the study population.
However, due to the similarity of the population age distributions, FIGURE 2 Likelihood of seeking healthcare for urinary symptoms according to overactive bladder (OAB) status and severity (all countries combined) for A, the entire study population (n = 7456) and B, men (n = 3688) and C, women (n = 3768) separately the variations between countries in overall population prevalence rates are expected to be similar to those reported here.
Herein we report that national OAB prevalence rates range between 23.9% (China) and 15.8% (Taiwan). The differences between countries could be related to a variety of different factors, including demographic variations in the study populations of the 3 countries, cultural differences (questions may not be interpreted consistently), lifestyle differences (factors such as obesity and caffeine consumption, which affect the risk of OAB, may not be consistent across countries), and ethnicity (some nationalities may be genetically more susceptible to OAB than others).
The association between OAB prevalence and age is not surprising because numerous previous studies of OAB in Europe and North America, 6, 7 as well as Asia, [8] [9] [10] 13, 14, 17 have reported that the prevalence of OAB generally increases with age. Similarly, the finding that individuals with neurological conditions have a much higher likelihood of OAB is expected because these individuals would be more likely to have detrusor overactivity. In the present study, marital status and educational level were found to also be associated with differences in OAB prevalence. The first of these associations may, potentially, be attributable to age. Single individuals (low OAB prevalence; mean age 44 years) were younger than the overall study population (mean age 54 years), and widows or widowers (high OAB prevalence; mean age 80 years) were older. The reasons for the variation according to educational level are not clear.
The present data indicate that severe OAB is highly likely to present with other LUTS. Most individuals with severe OAB (88%) were positive for all 3 ICS symptom groups. Therefore, in a patient presenting with OAB, it may be valuable to assess whether other symptoms are present to ensure appropriate treatment of all the patient's LUTS.
The OAB prevalence data in the present study appear broadly comparable with previous studies performed in Europe and North
America. The overall prevalence in the present study (20.8%) was higher than that observed in the EPIC study (11.8%) 5 and the National
Overactive Bladder Evaluation (NOBLE) program (16.5%). 6 In the present study, the population was aged ≥40 years, compared with ≥18 years in these previous 2 studies; this could have contributed to the observed differences among studies. There was no such age difference between the present study and a European telephone-based study reporting an OAB prevalence of 16.6%, 7 but this could be attributable to different methodologies (e.g. individuals may answer questions differently on the telephone compared with online).
Previous OAB prevalence studies conducted in Asia have reported variable results. Two previous studies in China have reported considerably lower OAB prevalence than the rate of 23.9% reported herein.
Specifically, Wen et al. 15 reported an OAB prevalence of 2.1%; as in the present study, OAB presence in that study was determined according to the OABSS and the population was aged ≥40 years. In another Chinese study, performed using ICS definitions in a population aged ≥18 years, OAB prevalence was 6.0%. 14 However, an OAB prevalence of 26.3% based on IPSS was reported in a Chinese study of men aged >50 years, 17 which is comparable with the prevalence of 21.4% among Chinese men aged ≥40 years in the present study.
A previous Korean study reported OAB prevalence to be 12.2%, 11 below the rate of 19.7% reported herein, but this difference could be attributable to the population in the other study being aged ≥18 years.
One Taiwanese study reported adult OAB prevalence to be 16.9%, 16 similar to the rate of 15.8% in Taiwanese men and women in the present study. However, another study conducted in Taiwan (in women only) reported higher OAB prevalence, ranging between 21.0% and 34.8% depending on the OAB definition used. 8 OAB prevalence rates above the levels reported herein have also been observed in 2 international Asian studies. Moorthy et al. 13 reported an OAB prevalence of 29.9% in Asian men, and Lapitan and Chye 10 estimated the prevalence among women to be 53.1%. Overall, differences between studies in OAB prevalence could be attributable to different criteria used to define OAB, and variations in age, culture, and ethnicity.
In the present study, OAB prevalence was higher in women than men, similar to findings from the EPIC study, 5 the NOBLE program, 6 and the European telephone-based study. 7 In the EpiLUTS study, participants were aged ≥40 years and OAB prevalence was higher in women, but the difference between the sexes was larger (31%-43%
in women vs. 13%-27% in men). 4 Higher OAB prevalence among women than men has been reported in Korea. 11 In contrast, other Asian studies suggest a higher prevalence of OAB in men. 9, 12, 15 Differences between study populations with regard to age may have contributed to these findings. Matsumoto et al. 12 reported that the prevalence of OAB increased with age in men; although the same was observed in women, the magnitude of the trend was reduced.
Accordingly, in a Taiwanese study, increased age was an independent risk factor for OAB in men but not in women. 16 The data from the study of Matsumoto et al. 12 suggest that OAB affects a higher proportion of women than men below the age of 50 years, but a higher proportion of men than women above the age of 50 years. In the present study, the relationship between age and OAB prevalence did not clearly differ between men and women, although, unlike men, women in the 2 oldest age groups (55-60 and >60 years) showed very similar rates of OAB.
The present study found that 46% of individuals with OAB were consulting a healthcare professional and that 67%-93% were receiv- In conclusion, OAB symptoms affect 1 in 5 men and women aged ≥40 years in China, Taiwan, and South Korea, and these symptoms become more common with increasing age. Although a significant proportion of individuals with OAB are being treated, the results suggest that many more individuals with OAB could benefit by consulting healthcare professionals to ensure that they receive the most effective available treatment. The findings reported herein have set the scene for further epidemiological studies across Asia to analyze the prevalence of OAB.
